Endoscopy 2006; 38(6): 632-638 DOI: 10.1055/s-2006-925086
Guidelines
© Georg Thieme Verlag KG Stuttgart · New York
Guidelines of the French Society for Digestive Endoscopy (SFED)
Management of Patients on Anticoagulants or Antiplatelet Agents before Digestive Endoscopy B. Napoléon1
, B. Boneu2
, L. Maillard3
, C.-M. Samama4
, J.-F. Schved2
, G. Gay1
, T. Ponchon1
, D. Sautereau1
, J.-M. Canard1 and the Board of the SFED1
1 Société Française d’Endoscopie Digestive (SFED)
2 Groupe d’Etude de l’Hémostase et de la Thrombose (GEHT)
3 Société Française de Cardiologie (SFC)
4 Société Française d’Anesthésie et de Réanimation (SFAR)
References
1
Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures.
Gastrointest Endosc.
2002;
55
775-779
2
Miller A M, McGill D, Bassett M L.
Anticoagulant therapy, antiplatelet agents and gastrointestinal endoscopy.
J Gastroenterol Hepatol.
1999;
14
109-113
3
Hittelet A, Devière J.
Management of anticoagulants before and after endoscopy.
Can J Gastroenterol.
2003;
17
329-332
4
Nelson D B, Freeman M L.
Major hemorrhage from endoscopic sphincterotomy : risk factor analysis.
J Clin Gastroenterol.
1994;
19
283-287
5
Bergman J J, Rauws E A, Fockens P, vanBerkel A M, Bossuyt P M, Tijssen J G. et al .
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones.
Lancet.
1997;
349
1124-1129
6
O’Laughlin J C, Hoftiezer J W, Mahoney J P, Ivey K J.
Does aspirin prolong bleeding from gastric biopsies in man?.
Gastrointest Endosc.
1981;
27
1-5
7
Waye J.
Colonoscopy.
CA Cancer J Clin.
1992;
42
350-365
8
Remine S G, Hughes R W, Weiland L H.
Endoscopic gastric polypectomy.
May Clin Proc.
1981;
56
371-375
9
Ahmad N A, Kochman M L, Long W B, Furth E E, Ginsberg G G.
Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases.
Gastrointest Endosc.
2002;
55
390-396
10
Binmoeller K F, Boaventura S, Ramsperger K, Soehendra N.
Endoscopic snare excision of benign adenomas of the papilla of Vater.
Gastrointest Endosc.
1993;
39
127-131
11
Cotton P B, Lehman G, Vennes J, Geenen J E, Russel R C, Meyers W C. et al .
Endoscopic sphincterotomy complications and their management : an attempt at consensus.
Gastrointest Endosc.
1991;
37
383-393
12
Mathus-Vliegen E M, Tytgat G N.
Nd:YAG laser photocoagulation in colorectal adenoma. Evaluation of its safety, usefulness and efficacy.
Gastroenterology.
1986;
90
1865-1873
13
Piai G, Cipolletta L, Claar M, Marone G, Bianco M A, Forte G. et al .
Prophylactic sclerotherapy of high rish esophageal varices : results of a multicentric prospective controlled trial.
Hepatology.
1988;
8
1495-1507
14
Stiegmann G V, Goff J S, Michaletz-Onody P A, Korula J, Lieberman D, Saeed Z A. et al .
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.
N Engl J Med.
1992;
326
1527-1532
15 Jensen D M. Endoscopic control of non variceal upper gastrointestinal hemorrhage. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW (eds) Textbook of gastroenterology. Philadelphia; Lippincott Williams and Wilkins 1999: 2857-2879
16
Napoléon B.
Ponction sous échoendoscopie: un geste utile ou dangereux?.
Gastroentérol Clin Biol.
1999;
23
459-462
17
Larson D E, Burton D D, Schroeder K W, DiMagno E P.
Percutaneous endoscopic gastrostomy. Indications, success, complications, and mortality in 314 consecutive patients.
Gastroenterology.
1987;
93
48-52
18
Neuhaus H, Hoffman W, Dittler H J, Niedermeyer H P, Classen M.
Implantation of self-expanding esophageal metal stents for palliation of malignant dysphagia.
Endoscopy.
1992;
24
405-410
19
Faigel D O.
Endoscopy for the diagnosis and management of esophageal cancer.
ASGE Clinical Update.
2000;
8
1-4
20
Dumortier J, Napoléon B, Hedelius F, Pellissier P E, Leprince E, Pujol B. et al .
Unsedated transnasal EGD in daily practice: Results with 1100 consecutive patients.
Gastrointest Endosc.
2003;
57
198-204
21
Patrono C, Coller B, Dalen J E, FitzGerald G A, Fuster V, Gent M. et al .
Platelet-active drugs: the relationships among dose, effectiveness, and optimal therapeutic range.
Chest.
2001;
119 (1 Suppl)
39S-63S
22
Samama C M, Djoudi R, Lecompte T, Nathan-Denizot N, Schved J F. and the AFSSAPS expert group .
Perioperative platelet transfusion: recommendations of the Agence française de sécurité sanitaire des produits de santé (AFSSaPS) 2003.
Can J Anesth.
2005;
52
30-37
23
Brochier M L. for the Flurbiprofen French Trial .
Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction.
Eur Heart J.
1993;
14
951-957
24
Shiffman M L, Farrel M T, Yee Y S.
Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDs.
Gastrointest Endosc.
1994;
40
458-462
25
Hui A J, Wong R MY, Ching J YL, Hung L CT, Chung S CS, Sung J JY.
Risk of colonoscopy polypectomy bleeding with anticoagulants and antiplatelet agents : analysis of 1657 cases.
Gastrointest Endosc.
2004;
59
44-48
26
Yousfi M, Gostout C J, Baron T H, Hernandez J L, Keate R, Fleischer D E, Sorbi D.
Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin.
Am J Gastroenterol.
2004;
99
1785-1789
27
Freeman M L, Nelson D B, Sherman S, Haber G B, Herman M E, Dorsher P J. et al .
Complications of endoscopic biliary sphincterotomy.
N Eng J Med.
1996;
335
909-918
28
Rogers J E, Fleming B G, Macintosh K C, Johnston B, Morgan-Hughes J O.
Effect of timing of ketorolac administration on patient-controlled opiod use.
Br J Anaesth.
1995;
75
15-18
29
Strom B L, Berlin J A, Kinman J L, Spitz P W, Hennessy S, Feldman H. et al .
Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study.
Jama.
1996;
275
376-382
30
Ferraris V A, Swanson E.
Aspirin usage and perioperative blood loss in patients undergoing unexpected operations.
Surg Gynecol Obstet.
1983;
156
439-442
31
CAPRIE Steering Committee .
A randomised, blinded trial of clopridrogel versus aspirin in patients at risk of ischemic events.
Lancet.
1996;
348
1329-1339
32
Conférence d’experts: Société Française d’Anesthésie et de Réanimation, Groupe d’étude sur l’hémostase et la thrombose de la société française d’hématologie .
Agents antiplaquettaires et période périopératoire. Paris:.
Elsevier,.
2002;
7-139
33
Kaluza G L, Joseph J, Lee J R, Raizner M E, Raizner A E.
Catastrophic outcomes of noncardiac surgery soon after coronary stenting.
J Am Coll Cardiol.
2000;
35
1288-1294
34
Boneu B, Schved J F, Lecompte T, Alessi M C. et le groupe d’études sur l’hémostase et la thrombose .
Utilisation des traitements antithrombotiques en pratique médicale courante.
STV numéro spécial.
2000;
12
2-55
35
Orford J L, Lennon R, Melby S, Fasseas P, Bell M R, Rihal C S. et al .
Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry.
J Am Coll Cardiol.
2002;
40
1567-1572
36
Leon M B, Baim D S, Popma J J, Gordon P C, Cutlip D E, Ho K K. et al .
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
N Engl J Med.
1998;
339
1665-1671
37
Recommandations de la Société Française de Cardiologie concernant les indications et la surveillance des traitements par anticoagulants oraux.
AMC.
1997;
9
1289-1305
38
Steinhubl S R, Berger P B, Mann J T 3rd, Fry E T, DeLago A, Wilmer C. et al .
CREDO investigators. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
Jama..
2003;
289
987
39
Waksman R, Ajani A E, White R L, Pinnow E, Dieble R, Bui A B. et al .
Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS).
Circulation.
2001;
103
2332-2335
40
Morice M C, Serruys P W, Sousa J E, Fajadet J, Ban Hayashi E, Perin M. RAVEL Study Group .
Randomized study with the Sirolimus-Coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
N Engl J Med.
2002;
346
1773-1780
41
Stein P D, Alpert J S, Bussey H I, Dalen J E, Turpie A G.
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
Chest.
2001;
119 (1 Suppl)
220S-227S
Dr. B. Napoleon
Société Française d’Endoscopie Digestive (SFED)
35 rue Bataille · 69008 Lyon · France ·
Telefon: +33-478-78-10-51
Fax: +33-478-74-07-92
eMail: bertrand.napoleon@libertysurf.fr